Product Information
AMBRISENTAN 10 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $8.5213 per EA under NDC 82009014230. Its NADAC has been published 32 times since Nov 19, 2025.
Strength
10 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009014230
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMBRISENTANApproval Type
Generic (ANDA)
FDA Application
ANDA210058On Market Since
5/1/2024
Pharmacological Classes
Price Statistics
The NADAC for AMBRISENTAN 10 MG TABLET has been published 32 times since Nov 19, 2025, and over the history we have for it it has declined 13.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.5213 per EA |
|---|---|
| All-time high | $9.8462 (Dec 10, 2025) |
| All-time low | $8.2876 (Apr 22, 2026) |
| 52-week high | $9.8462 |
| 52-week low | $8.2876 |
| Median price | $8.5205 |
| Average price | $8.7379 |
| Largest weekly change | -7.8% (Dec 17, 2025) |
| Weeks tracked | 32 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMBRISENTAN 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AMBRISENTAN 10 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $8.5213 per EA (NDC 82009014230), effective Jun 24, 2026.
How has the price of AMBRISENTAN 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for AMBRISENTAN 10 MG TABLET has declined 13.5%. It has been tracked across 32 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for AMBRISENTAN 10 MG TABLET?
Since Nov 19, 2025, the NADAC for AMBRISENTAN 10 MG TABLET has ranged from a low of $8.2876 (Apr 22, 2026) to a high of $9.8462 (Dec 10, 2025), with a median of $8.5205 per EA.
Are there cheaper alternatives to AMBRISENTAN 10 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as AMBRISENTAN 10 MG TABLET, but none are currently priced below it.
Who manufactures AMBRISENTAN 10 MG TABLET?
AMBRISENTAN 10 MG TABLET (NDC 82009014230) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification